Research Article
A Novel Capsule Lumbar Interbody Fusion (CLIF) in Treating Foot Drop due to Lumbar Degenerative Diseases: a Prospective, Observational Study
Table 1
Clinical characteristics of patients in the TLIF group and CLIF group.
| Parameters | Total | TLIF | CLIF | |
| Age (years, median (range)) | 46 (26–69) | 43 (27–60) | 46 (26–69) | 0.895 | Gender (N, female/male) | 6/21 | 3/12 | 3/9 | >0.999 | Duration of symptoms (months, median (range)) | 12 (0.3–120) | 12 (0.3–120) | 10 (0.3–120) | 0.837 | Duration of foot drop (days, median (range)) | 150 (6–1460) | 182 (6–365) | 105 (7–1460) | 0.761 |
| Intraoperative parameters | Operation time, (mins, median (range)) | 120 (75–260) | 120 (75–230) | 155 (100–260) | 0.390 | Blood loss (ml, median (range)) | 200 (50–1000) | 100 (50–1000) | 200 (50–600) | 0.397 |
| Surgical segments | 1 level | 16 | 9 | 7 | | 2 levels | 9 | 5 | 4 | | 4 levels | 2 | 1 | 1 | | Duration of follow-up (months, median (range)) | 19 (13–28) | 19 (13–27) | 19.5 (14–28) | 0.513 |
|
|